Literature DB >> 15753095

Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria.

Yoshimi Arima1, Masayuki Nitta, Shinji Kuninaka, Dongwei Zhang, Toshiyoshi Fujiwara, Yoichi Taya, Mitsuyoshi Nakao, Hideyuki Saya.   

Abstract

The tumor suppressor p53 functions as a transcriptional activator to induce cell cycle arrest and apoptosis in response to DNA damage. Although p53 was also shown to mediate apoptosis in a manner independent of its transactivation activity, the mechanism and conditions that trigger such cell death have remained largely unknown. We have now shown that inhibition of RNA polymerase II-mediated transcription by alpha-amanitin or RNA interference induced p53-dependent apoptosis. Inhibition of pol II-mediated transcription resulted in down-regulation of p21Cip1, which was caused by both transcriptional suppression and protein degradation, despite eliciting p53 accumulation, allowing the cells to progress into S phase and then to undergo apoptosis. This cell death did not require the transcription of p53 target genes and was preceded by translocation of the accumulated p53 to mitochondria. Our data thus suggested that blockade of pol II-mediated transcription induced p53 accumulation in mitochondria and was the critical factor for eliciting p53-dependent but transcription-independent apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15753095     DOI: 10.1074/jbc.M410691200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Convergent transcription through a long CAG tract destabilizes repeats and induces apoptosis.

Authors:  Yunfu Lin; Mei Leng; Ma Wan; John H Wilson
Journal:  Mol Cell Biol       Date:  2010-07-20       Impact factor: 4.272

2.  Monoubiquitylation promotes mitochondrial p53 translocation.

Authors:  Natasha D Marchenko; Sonja Wolff; Susan Erster; Kerstin Becker; Ute M Moll
Journal:  EMBO J       Date:  2007-02-01       Impact factor: 11.598

Review 3.  Regulation of mitochondrial DNA content and cancer.

Authors:  Masahiro Higuchi
Journal:  Mitochondrion       Date:  2006-12-05       Impact factor: 4.160

4.  RPA and ATR link transcriptional stress to p53.

Authors:  Frederick A Derheimer; Heather M O'Hagan; Heather M Krueger; Sheela Hanasoge; Michelle T Paulsen; Mats Ljungman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-06       Impact factor: 11.205

Review 5.  Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.

Authors:  Nadi T Wickramasekera; Gokul M Das
Journal:  Mitochondrion       Date:  2013-10-29       Impact factor: 4.160

6.  Circadian gene expression is resilient to large fluctuations in overall transcription rates.

Authors:  Charna Dibner; Daniel Sage; Michael Unser; Christoph Bauer; Thomas d'Eysmond; Felix Naef; Ueli Schibler
Journal:  EMBO J       Date:  2008-12-11       Impact factor: 11.598

7.  Apoptotic actions of p53 require transcriptional activation of PUMA and do not involve a direct mitochondrial/cytoplasmic site of action in postnatal cortical neurons.

Authors:  Takuma Uo; Yoshito Kinoshita; Richard S Morrison
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

8.  Modulation of p53, c-fos, RARE, cyclin A, and cyclin D1 expression in human leukemia (HL-60) cells exposed to arsenic trioxide.

Authors:  Clement G Yedjou; Paul B Tchounwou
Journal:  Mol Cell Biochem       Date:  2009-05-15       Impact factor: 3.396

9.  Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation.

Authors:  Sanjeev Shukla; Sanjay Gupta
Journal:  Free Radic Biol Med       Date:  2008-02-26       Impact factor: 7.376

10.  The cyclin-dependent kinase inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole induces nongenotoxic, DNA replication-independent apoptosis of normal and leukemic cells, regardless of their p53 status.

Authors:  Valentina Turinetto; Paola Porcedda; Luca Orlando; Mario De Marchi; Antonio Amoroso; Claudia Giachino
Journal:  BMC Cancer       Date:  2009-08-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.